Lemaitre Vascular LMAT
NASDAQ LMAT
$80.19 -2.40 (-2.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lemaitre Vascular (LMAT) Convertible Debt (2024 - 2026)

Updated

Lemaitre Vascular (LMAT) recorded Convertible Debt of $169.09 million in Q2 2026, up 0.5% from $168.21 million a year earlier and up 0.1% from the prior quarter.

Analysis

Lemaitre Vascular (LMAT) Convertible Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Lemaitre Vascular reported Convertible Debt of $168.65 million, up 0.5% from FY2024.

  • Across earlier years, Convertible Debt came in at $167.77 million in FY2024.
  • On a year-over-year basis, Convertible Debt has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $168.87 million (Q1 2026), $168.65 million (Q4 2025) and $168.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Lemaitre Vascular 1.89 Bn 442.77 Mn 50.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 169.09 Mn
Mar 31, 2026 168.87 Mn
Dec 31, 2025 168.65 Mn
Sep 30, 2025 168.42 Mn
Jun 30, 2025 168.21 Mn
Mar 31, 2025 167.98 Mn
Dec 31, 2024 167.77 Mn
API Access

Lemaitre Vascular Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LMAT&period=max&api_key=YOUR_API_KEY